Neo-adjuvant Chemotherapy Combined With Stereotactic Body Radiotherapy to the Primary Tumour +/- Durvalumab, +/- Oleclumab in Luminal B Breast Cancer:

计划入组 147 人 · 首次发布于 2019 年 3 月 14 日

Investigation of Genomic Alteration in Patients With Luminal A or Luminal B Subtypes

计划入组 750 人 · 首次发布于 2020 年 5 月 27 日

Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC

首次发布于 2014 年 5 月 16 日

Haemagglutinin-strain B (Yamagata-like)(Afluria Tetra, FluLaval Tetra, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra)

Haemagglutinin-strain B (Victoria-like)(Afluria Tetra, FluLaval Tetra, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra)

Influenza virus type B

AB&B BIO-TECH-B

B R B Software Systems Inc

United States

VIGONVITA-B

Denosumab Shows Immunomodulatory Effects in HER2-Negative Early Breast Cancer

Luminal A DCIS Shows Strong Response to Letrozole in Phase II Trial, Genomic Study Reveals

First Predictive Biomarker for Hormone Therapy in Recurrent Prostate Cancer Validated in Phase II BALANCE Trial